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ABSTRACT
Proteolytic processing of the CUX1 transcription
factor generates an isoform, p110 that accelerates
entry into S phase. To identify targets of p110 CUX1
that are involved in cell cycle progression, we
performed genome-wide location analysis using a
promoter microarray. Since there are no antibodies
that specifically recognize p110, but not the full-
length protein, we expressed physiological levels of
a p110 isoform with two tags and purified chromatin
by tandem affinity purification (ChAP). Conventional
ChIP performed on synchronized populations of
cells confirmed that p110 CUX1 is recruited to the
promoter of cell cycle-related targets preferentially
during S phase. Multiple approaches including
silencing RNA (siRNA), transient infection with
retroviral vectors, constitutive expression and
reporter assays demonstrated that most cell cycle
targets are activated whereas a few are repressed
or not affected by p110 CUX1. Functional classes
that were over-represented among targets included
DNA replication initiation. Consistent with this
finding, constitutive expression of p110 CUX1 led
to a premature and more robust induction of
replication genes during cell cycle progression,
and stimulated the long-term replication of a
plasmid bearing the oriP replicator of Epstein Barr
virus (EBV).
INTRODUCTION
CDP/Cux/Cut (CCAAT-displacement protein/cut homeo-
box) proteins are a family of transcription factors present
in all metazoans and involved in the control of prolifera-
tion and diﬀerentiation (1). The literature in mammals
includes a variety of terms, and recently the Human
Genome Organization (HUGO) proposed to change from
the gene root of CUTL# (CUT-Like #) to CUX#.
Thus, the term CUX1 will be used thereafter in the text
to designate the human or mouse protein. At least four
CUX1 protein isoforms can be expressed as the result
of proteolytic processing or transcription initiation at an
alternative start site: p200, p150, p110 and p75 (2–5).
The full-length protein, p200 CUX1, contains four DNA-
binding domains: three Cut repeats (CR1, CR2 and CR3)
and a Cut homeodomain (HD) (see Figure 1 for maps) (5).
This isoform makes a rapid but unstable interaction with
DNA and is responsible for the CCAAT-displacement
activity that has been reported in earlier studies (1,6).
CUX1 was originally found to function as a transcrip-
tional repressor, but more recent studies showed that the
short isoforms repress or activate transcription depending
on promoter context (4,7–13). In particular, p110 was
found to transactivate a DNA pol a gene reporter in
transient transfection assays and to stimulate expression
of the endogenous DNA pol a gene following retroviral
infection. Using in vitro and in vivo DNA-binding assays
in conjunction with mutated versions of the promoter,
a correlation was established between transcriptional
stimulation and binding of CUX1 to the promoter (12).
Knockout and transgenic mouse models revealed cell-
autonomous as well as non-cell-autonomous phenotypes
in multiple organs and tissues (14–18). Cell-based assays
have established a role for CUX1 in at least two processes:
cell cycle progression and cell motility (19,20). A number
of studies demonstrated that CUX1 is regulated in a cell
cycle-dependent manner and may have a speciﬁc function
in S phase. The histone nuclear factor D (HiNF-D), which
was later found to include CUX1 as its DNA-binding
moiety, was shown to be up-regulated in S phase in
normal cells but to be constitutively expressed in various
tumor cells (21–25). In NIH3T3 cells, the up-regulation of
stable DNA binding at the G1/S transition was shown
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to involve at least two post-translational modiﬁcations:
dephosphorylation of the Cut homeodomain by the
Cdc25A phosphatase, and proteolytic cleavage of p200
CUX1 by a nuclear isoform of cathepsin L (2,4,26).
Proteolytic processing of p200 CUX1at the end of the G1
phase generates the p110 isoform, which contains three
DNA-binding domains (CR2, CR3 and HD) and binds
stably to DNA (4). Populations of cells stably expressing
p110 CUX1 displayed a faster division rate and reached
higher saturation density than control cells (20).
In various experimental conditions, p110-expressing cells
reached the next S phase faster than control cells: follow-
ing cell synchronization in G0 by growth factor depriva-
tion, synchronization in S phase by double thymidine
block treatment, or enrichment in G2 by centrifugal
elutriation. In each case, the G1 phase was shortened by
2–4 h (20). Later in the cell cycle, both cyclin A/Cdk2 and
cyclin A/Cdk1 were found to interact with p110 CUX1,
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Figure 1. Strategy for the identiﬁcation of transcriptional targets of p110 CUX1. (A) The methodology used to identify gene targets of p110 CUX1
is summarized in a ﬂowchart and is described in the text. (B) HeLa cells were infected with a retroviral vector expressing a recombinant p110 CUX1
protein with two tags at its C-terminus. Nuclear extracts were prepared from each population of cells and analyzed by western blot using the 861 and
1300 CUX1 antibodies. Below is a schematic representation of CUX1 proteins with some of the functional domains: ID, inhibitory domain;
CC, coiled-coil; CR1, CR2 and CR3, Cut repeat 1, 2 and 3; HD homeodomain; CBD, calmodulin-binding domain; Prot A, protein A. The regions
recognized by the 861 and 1300 antibodies are shown. (C) Protein samples from each step of the Taptag puriﬁcation were analyzed by western blot
using the anti-calmodulin-binding protein epitope (CBP) Tag antibody. Nuclear extract (lane 1); IgG beads ﬂowthrough (F.T., lane 2); or bound
(lane 3); after TEV digestion, cleaved and eluted from IgG beads (lane 4) or still bound to IgG beads (lane 5); bound to calmodulin beads (lane 6)
and eluted with EGTA (lane 7). Note that digestion with TEV removes one tag and reduces the size of the recombinant protein. (D) Chromatin from
Hs578T/p110-Tag2 and Hs578T/vector cells was submitted to tandem aﬃnity puriﬁcation and analyzed by PCR using primers speciﬁc for the
CCNA2, DLX2 and G6PDH gene promoters. Representative data from three independent ChAP experiments are presented. (E) The puriﬁed
chromatin from Hs578T/p110-Tag2 cells was ampliﬁed by ligation-mediated PCR prior to the hybridization. The enrichment level of the CCNA2 and
DLX2 gene promoters was measured by quantitative real-time PCR (qPCR) before and after LM-PCR. The results represent the mean  SD from
three independent ChAP experiments and their ampliﬁcation.
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but only cyclin A/Cdk1 was able to phosphorylate serine
1237 thereby causing inhibition of DNA binding during
the G2 phase (27,28).
In the present study, we performed genome-wide
location analysis for p110 CUX1 using chromatin aﬃnity
puriﬁcation (ChAP). Cell cycle targets were validated by
conventional ChIP and cell synchronization experiments.
Functional annotation revealed an over-representation
of genes with various functions required for cell-cycle
progression, notably DNA replication and mitosis. In cell-
based assays, p110 CUX1 did not aﬀect progression
through the G2 and M phases, but was able to stimulate
the long-term maintenance of a plasmid carrying the
oriP replicator of EBV. Multiple molecular approaches
demonstrated that p110 CUX1 transcriptionally activates
many genes that play a role in DNA replication. Overall,
these results suggest that p110 CUX1 accelerates the start
of DNA replication by activating transcription of genes
required for DNA replication.
MATERIALS AND METHODS
Cell culture
NIH3T3, HeLa, HEK293 and Hs578T cells were main-
tained in Dulbecco’s modiﬁed minimum essential medium
(DMEM) supplemented with penicillin–streptomycin,
glutamine and 10% fetal bovine serum (FBS) (Gibco)
(5% FBS for Hs578T). K562, HEL, Ramos, U266,
RPMI8266 cells were grown in RPMI 1640 (Wisent)
containing 10% FBS, glutamine and penicillin–
streptomycin.
Retroviral infection and stable cell lines
Retroviruses were produced by transfecting 293VSV cells
with the pREV/TRE vector either empty or encoding p110
CUX1-Tag2 (CUX1 aa 612–1336 with protein A and CBP
tags inserted at the C-terminus) (Clontech). Preparation
of the retroviruses and the eight stable cell lines was done
as previously described (20).
Chromatin immunoprecipitation (ChIP)
For ChIP, we used 4 108 HeLa cells, either unsynchro-
nized or synchronized by a single thymidine block.
Immunoprecipitation of endogenous CUX1 was done
using anti CUX1 antibodies 861 and 1300 (4). The nuclei
were puriﬁed as described in Ref. (29), then lyzed in
RIPA-M buﬀer (10mM Tris–HCl pH 8, 1mM EDTA,
0.5mM EGTA, 150mM NaCl, 1% Triton X-100, 0.5%
DOC, 0.1% SDS, 1mM PMSF, protease inhibitors) and
sonicated on ice to obtain 250- to 800-bp-long DNA
fragments. Un-enriched input chromatin was put aside as
a control. After preclearing for 1h and incubation with
antibodies overnight, immunocomplexes were washed
3 times each in wash buﬀer I (20mM Tris–HCl pH 8,
2mM EDTA, 2mM EGTA, 150mM NaCl, 1% NP-40,
0.5% DOC, 0.2% SDS), wash buﬀer II (20mM Tris–HCl
pH 9, 2mM EDTA, 2mM EGTA, 500mM NaCl, 1%
NP-40, 0.5% DOC, 0.1% SDS), wash buﬀer III (50mM
Tris–HCl pH 7.5, 2mM EDTA, 1mM EGTA, 0.5M LiCl,
1% NP-40, 0.7% DOC,) and then washed once in Tris–
EDTA. Cross-linked DNA was eluted with 1% SDS,
10mM Tris–HCl pH 8, 10mM EDTA at 658C for 30min.
After reversal of formaldehyde cross-linking, chipped
DNAs were treated with RNase A and Proteinase K.
Enrichment calculation
ChIP experiments were analyzed by real-time PCR using
the FastStart DNA Master SYBR Green kit (Roche).
Fold enrichment of target promoters was calculated in
two steps. First, the fold enrichment for each target gene
was determined relative to a negative control (G6PDH
promoter) and was expressed as percentage of input.
Second, the speciﬁc enrichment was calculated by dividing
the enrichment level in the sample obtained with CUX1
antibody by the (non-speciﬁc) enrichment level in the
sample obtained with no antibody.
Chromatin affinity purification (ChAP)
For each cell line, the ChAP-chip procedure was perfor-
med independently at least 3 times, each time comparing
the p110-Tag2 and the vector alone stable line. A total of
3 to 6 108 cells were used for each puriﬁcation. Total
chromatin was obtained and sonicated as described above
and a fraction was put aside as un-enriched input control.
Stably expressed recombinant p110-Tag2 protein was
puriﬁed by the Taptag puriﬁcation method with some
modiﬁcations (30). The cross-linked sonicated DNA
was prepared in the same way as in the ChIP. The IgG
matrix bound p110-Tag2/DNA were washed with above-
mentioned wash buﬀers I, II and III, and then TEV buﬀer
(10mM Tris–HCl (pH 8.0), 100mM NaCl, 0.1% TX-100,
0.5mM EDTA, 10% glycerol, 1mM DTT). After TEV
protease digestion, the released protein–DNA complexes
were puriﬁed by aﬃnity chromatography on calmodulin
beads in the presence of calcium and then eluted with
EGTA. After de-cross-linking, samples were treated
with RNase A and Proteinase K. In all experiments,
each puriﬁcation step was monitored by immunoblotting
with polyclonal antibodies against the calmodulin-binding
domain epitope tag or against CUX1. A detailed protocol
for ChAP-chip is provided as a Word ﬁle in the
Supplementary Data.
Probe generation and microarray hybridization
For each cell line, microarray hybridizations were
performed 3 times using independently obtained ChAP-
enriched and input DNAs. The generation of labeled
DNAs from individual ChAP samples was performed
following the protocol of linker-mediated PCR
(LM-PCR) as detailed previously (31). Brieﬂy, ChAPped
DNAs and input DNA were blunted, ligated to a unidirec-
tional linker and ampliﬁed by PCR for 24 cycles to
generate a suﬃcient amount of DNA. In all experiments,
the enrichment level of the DLX2 gene promoter before
and after LM-PCR ampliﬁcation was veriﬁed by real-time
PCR. ChAP and input DNAs were ﬂuorescently labeled
with Cy5 ﬂuorophore and Cy3 ﬂuorophore, respectively,
by using BioPrime Array CGH genomic labeling kit
following the manufacturer’s instructions (Invitrogen).
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Prior to hybridization, microarray slides were incubated in
a blocking solution, 1.6% succinic anhydride in 1-methyl-
2-pyrrolidinone, for 20min at RT. After washing, labeled
DNAs were added to the hybridization buﬀer (25%
Formamide, 5 SSC, 0.1% SDS, 0.2% BSA, 0.4 mg/ml of
human Cot-1 DNA, 0.8 mg/ml of yeast tRNA) and
hybridized at 558C for 20 h. The slides were washed once
with 2 SSC, 0.1% SDS for 15min, twice 2min with 0.1
SSC, 0.1% SDS, twice 1min 0.1 SSC and then spun
dried. Hybridized slides were scanned with an Axon 4000b
scanner and the acquired images were analyzed with the
software GenePix Pro, Version 4.1.
Microarray design
A microarray containing 19k human promoters was
generated as reported (32). In brief, the regions ranging
from 800 bp upstream and 200 bp downstream of the
transcription start sites from 18 660 human genes were
ampliﬁed by PCR and QC tested and applied on an
Poly-L-lysine glass slides together with 188 controls
located in exons and far from any known genes.
Microarray data analysis
The analysis of the ChAP-chip results was done as
described (33). Promoters were considered ‘bound’ when
the binding P-value in the error model was <0.005.
Functional categories were established using the online
DAVID (Database for Annotation, Visualization and
Integrated Discovery) software, available at: http://david.
niaid.nih.gov/david. Classes with a P-value <0.02 were
considered over-represented.
Promoter sequence analysis
Promoter sequences were determined by extending the
microarray probe by 250 bp both upstream and down-
stream. Occurrence of ATCRAT and CCAAT sequences
in CUX1 targets (n ¼ 52) and non-targets (n ¼ 55),
as deﬁned by ChAP-Chip results, were determined using
the MacVector software.
Western and Southwestern assays
Western blotting was performed as previously described
(4). Southwestern blotting was performed as previously
described using a double-stranded oligonucleotide probe
containing the CUX1 consensus-binding site: CGATA
TCGAT (34).
Pixel quantiﬁcation was done with the Scion Image
1.63 software.
Luciferase assay
Luciferase reporters were constructed as follows: PCR
ampliﬁcation was performed to obtain fragments of
genomic DNA containing the sequence present on the
microarray plus at least 250 bp on either side. The frag-
ments were cloned into the luciferase reporter vector,
pGL3 (Promega). Assays were performed as previously
described (12).
Expression analysis of p110 CUX1 target genes
Total RNA was extracted and RT-PCR was carried out
as previously described (19). Expression levels of the
genes were determined by real-time PCR using G6PDH
as an internal control. As for infection analysis, Hs578T
cells were infected with an empty vector or a retrovirus
expressing p110 CUX1 and total RNA was extracted 24 h
post-infection. For siRNA knockdown experiments,
NIH3T3 cells were transfected with either CUX1-speciﬁc
siRNA or a scrambled RNA by using Lipofectmine2000
reagent (InVitrogen) and total RNA was extracted 48 h
post-transfection. Serum starvation experiments using
NIH3T3 stably expressing p110 CUX1 or carrying the
empty vector were performed as described previously (19).
Cells were harvested at indicated time points.
Cell synchronization and FACS analysis
For ChIP, HeLa cells were synchronized by a single
thymidine block (2mM thymidine, 16 h). Double thymi-
dine block and serum starvation/stimulation were
performed as previously described (20). Cell cycle analysis
was done by FACS and the cell cycle distribution was
determined using the Watson model and the FlowJoTM
software (20).
EBV plasmid long-term maintenance assays
Hs578T cells stably expressing p110 CUX1 or carrying the
empty vector were transfected with 1 mg of pc3oriPE
plasmid by using the Lipofectamin 2000 reagent and cells
were grown in 800 mg/ml of G418 for up to 10 days (35).
Drug-resistant colonies from long-term maintenance assay
were visualized by staining with crystal violet. Quantiﬁca-
tion was done with the Scion Image 1.63 software.
RESULTS
Establishment and validation of the chromatin affinity
purification (ChAP) method
Our goal was to identify targets that are bound speciﬁcally
by the p110 isoform of CUX1. As p110 CUX1 is gene-
rated by proteolytic processing of p200 CUX1, the entire
primary sequence of p110 is contained within p200 and,
in spite of our attempts, there is currently no CUX1
antibody that can recognize p110 at the exclusion of p200.
We therefore developed an alternate strategy to identify
the p110-speciﬁc targets. We established populations
of cells stably expressing physiological levels of a p110
CUX1 protein with two epitope tags at its C-terminus,
p110-Tag2, and we puriﬁed chromatin by tandem aﬃnity
puriﬁcation (TAP) (36). We refer to this procedure as
chromatin aﬃnity puriﬁcation (ChAP) and the subsequent
microarray analysis as ChAP-chip (Figure 1A, see also
the ChAP-chip protocol in Supplementary Data). To
ensure that the recombinant p110-Tag2 protein would
be expressed at moderate level, we employed the
pRevTRE retroviral vector (Clontech), which contains
the minimal CMV promoter with a tetracycline-responsive
element. Retrovirally infected cells typically carry only
one or a few copies of the viral DNA. In the absence
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of a tetracycline-responsive transactivator, basal expres-
sion from the pRevTRE vector was previously shown to
be very low (37–39). Indeed, p110-Tag2 was expressed at
relatively low level in our population of HeLa/p110-Tag2
cells (Figure 1B). Similar results were obtained with the
other populations in the absence of tetracycline (data not
shown). In addition, we isolated six independent HeLa/
p110-Tag2 clones and veriﬁed that expression did not vary
signiﬁcantly among individual clones (data not shown).
The p110-Tag2 protein was followed by immunoblot-
ting through each step of the tandem aﬃnity puriﬁcation
protocol (Figure 1C). To verify the speciﬁcity of the
method, we tested for the presence of two known targets
of CUX1, CCNA2 (cyclin A2) and DLX2, in chromatin
samples that had been puriﬁed by aﬃnity chromatography
from cells expressing p110-Tag2 or from control cells
carrying the empty retroviral vector [(20) and unpublished
data]. Whereas the CCNA2 and DLX2 genes were present
in the chromatin puriﬁed from p110-Tag2 cells, these genes
could not be detected in the chromatin from control cells
(Figure 1D). Moreover, real-time qPCR was performed
for all samples to ensure that the enrichment level was not
changed following LM-PCR ampliﬁcation of the puriﬁed
DNA (Figure 1E).
Strategy to identify targets of p110 CUX1
We performed location analysis using a panel of eight
human cell lines of various cell types: breast tumor
(Hs578T), cervix carcinoma (HeLa), kidney epithelial
(HEK293), myeloid leukemia (K562, HEL) and B cell
lymphoma (Ramos, U266, RPMI8266). For each cell
line, hybridization experiments were done in triplicate
using three independent ChAP-enriched and input
DNA samples (8 cell lines  3 hybridizations ¼ 24).
ChAP-enriched DNA regions associated with p110 CUX1
were puriﬁed and labeled with Cy5 dye. Equal amounts
of Cy5-labeled ChAP products and Cy3-labeled input
DNA samples were co-hybridized onto a human promoter
microarray. We utilized a genomic DNA microarray
containing the region spanning 800 bp upstream and
200 bp downstream of transcription start sites of 18 660
human genes (32).
To determine the P-value threshold that would be used,
we performed standard PCR analysis on 37 randomly
selected targets using ChAP-enriched chromatin obtained
from Hs578T cells expressing the p110-Tag2 protein
or carrying the empty vector (Figure 2). All targets with
a P-value under 4 103 were conﬁrmed, whereas 5 out
of 6 targets with P-values between 4 and 5 103 were
conﬁrmed (Figure 2). Based on these experiments, we used
P< 0.005 because our estimated false-positive rate was
less than 3% using this threshold. Importantly, none of
the randomly tested targets was found to be present in the
chromatin that was puriﬁed from cells carrying the empty
vector (Figure 2). However, as an additional control,
hybridization of the promoter array was performed in
triplicate with chromatin puriﬁed from a cell line carrying
the empty vector. These experiments led to the identiﬁca-
tion of a total of 19 genes with a P-value under 0.005
(Supplementary Table 5). These genes were removed from
our list of putative targets.
Scanning ChAP analysis was performed on three loci,
AATF, RARB and SUV39H1, to verify where p110
CUX1 was recruited within the locus. In each case, a
signal was observed in the region immediately upstream of
the transcription start site and nowhere else (Figure 3).
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Figure 2. PCR analysis of target promoters with various P-values.
Chromatin from Hs578T/p110-Tag2 and Hs578T/vector cells was
submitted to tandem aﬃnity puriﬁcation and analyzed by PCR using
primers speciﬁc for each promoter. Input DNA (0.1%) was used as
control. Note that the region to be ampliﬁed was chosen to be approx-
imately in the middle of the sequence spotted on the location array.
The P-values were obtained from microarray hybridizations performed
in triplicate and comparing three independent ChAP-enriched and
input DNA samples.
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We conclude that p110 CUX1 is recruited speciﬁcally
to the promoter region of these three genes.
Over-representation of cell cycle functions among
targets of p110 CUX1
To verify whether speciﬁc cellular functions were over-
represented among the putative target genes of p110
CUX1, a single list was compiled from the eight cell lines
(Supplementary Table 6). A hierarchy of functional cate-
gories was established using the online DAVID software.
Among the functional classes most over-represented were
mitosis, DNA replication initiation, mismatch repair and
antigen processing via MHC class I (Table 1). The list of
genes that play a role in proliferation and cell cycle
progression is shown in Table 2.
Conventional ChIP confirms the recruitment of CUX1
to the promoters of cell cycle targets in S phase
CUX1 should bind a cell cycle target in all cell lines
independently of the tissue-type of origin. Yet we noticed
that not all targets displayed a P-value below 0.005 in
all eight cell lines (Supplementary Table 6). To explain
this discrepancy, we considered the possibility that the
recruitment of CUX1 to cell cycle gene promoters
occurred primarily in S phase as previously demonstrated
(12). As a consequence, the signals in microarray hybridi-
zations would be expected to be relatively weak since only
a small fraction of cells are in S phase in a population
of asynchronously proliferating cells. We set out to test
this hypothesis and, at the same time, verify whether the
endogenous CUX1 protein was binding to the promoters
of cell cycle genes. Conventional ChIP was performed
using CUX1 antibodies and HeLa cells either unsynchro-
nized or enriched in S phase by the thymidine block
procedure. FACS analysis of the cell cycle distribution
indicated that the proportion of cells in S phase was
increased almost 3-fold following the thymidine block
(Figure 4A). Although the expression level of p110 CUX1
was constant, the intrinsic DNA-binding aﬃnity of p110
CUX1 was clearly increased as judged from Southwestern
blotting (Figure 4B, lanes 1–2 and 3–4). Pixel quantiﬁca-
tion of three independent experiments, using the Scion
Image software, estimated to 2.7 0.54-fold the increase
in DNA binding in cells treated with thymidine. These
observations are in agreement with what was reported in
previous studies (4,12,28,40). Quantitative PCR analysis
was performed on 49 gene promoters using ChIP-enriched
chromatin from the two populations of cells. We observed
a moderate enrichment of targets in the unsynchronized
cells (Table 2, column 4). However, the enrichment was
consistently much higher when the chromatin was taken
from a population of cells enriched in S phase (Table 2,
column 5). These results suggest that in most cases
B
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Figure 3. Scanning ChAP analysis of the AAFF, RARB and SUV39H1
genes. Chromatin from Hs578T/p110-Tag2 cells was submitted to
tandem aﬃnity puriﬁcation and analyzed by PCR using primers speciﬁc
for diﬀerent regions of the following loci: AAFF (A), RARB (B) and
SUV39H1 (C). Templates for the PCR reactions were 0.1% total input
DNA (T) or ChAP-puriﬁed DNA (AP). Exons are numbered and the
transcription start sites are indicated by arrows. The positions of
ampliﬁed fragments are indicated over the maps and primer sequences
are given in Supplementary Table 7.
Table 1. Functional classes among transcriptional targets of p110
CUX1
Biological Process (level 5)
Function Alla Boundb P-value
Mitosis 1.04% 2.05% 0.0075
DNA replication initiation 0.26% 0.82% 0.0083
Mismatch repair 0.20% 0.68% 0.0106
Antigen processing via MHC class I 0.15% 0.68% 0.0028
Genes that were bound by p110 CUX1 were compared with all genes
present on the microarray by using a web-based functional annotation
tool, DAVID. Over-represented functions that are statistically signiﬁ-
cant (cutoﬀ P-value <0.02) are shown.
a‘All’ designates all genes that were spotted on the microarray.
b‘Bound’ designates the genes enriched in the ChAP-chip experiments
with p110.
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p110 CUX1 binds to the promoter of cell cycle genes
primarily during S phase. Importantly, all 49 cell cycle
targets were validated by conventional ChIP in cells
enriched in S phase.
Sequence analysis of target promoters
A motif-ﬁnding algorithm was used to identify
sequences that are over-represented in the promoters
of targets genes. The CUX1 consensus-binding site,
ATCRAT (R¼A or G), was the most frequent motif
found in the p110-bound promoters (Table 3) (41).
Further inspection of promoter sequences did not reveal
a particular arrangement of these motifs relative to the
transcription start site as they appear to be randomly
distributed. In contrast to the ATCRAT sequence, the
CCAAT motif and the consensus-binding site for the Cut
repeats 1 and 2, CRAT-CRAT, were not over-represented
Table 2. Transcriptional targets of p110 CUX1 that play a role in cell cycle
Function Gene symbol Gene description ChIP/qPCR: Fold/total
Unsync. Thymidine
Cell cycle, S phase CCNA2 Cyclin A2 1.6 5.1
CDC25A Cell division cycle 25A 2.5 7.5
Cell cycle, G2/M CDC25B Cell division cycle 25B 2.1 5.6
CDC25C Cell division cycle 25C 0.7 3.2
MAD2L1 MAD2 mitotic arrest deﬁcient-like 1 (yeast) 1.2 3.7
Cell cycle, M Phase ANAPC4 Anaphase-promoting complex subunit 4 2.9 4.8
APC10 Anaphase-promoting complex subunit 10 1.8 2.6
EML4 Echinoderm microtubule-associated protein-like 4 2.6 4.0
FNBP4 Formin-binding protein 4 1.7 14.1
FZR1 Fzr1 protein 3.7 24.6
KIF11 Kinesin family member 11 2.0 8.0
KNSL7 Kinesin-like 7 1.8 4.7
KNTC1 Kinetochore-associated 1 0.7 7.9
LATS1 Large tumor suppressor 1 5.0 11.8
NUMA1 Nuclear mitotic apparatus protein 1 1.9 2.2
PRC1 Protein regulator of cytokinesis 1 3.6 5.5
SKB1 SKB1 homolog (S. pombe) 1.8 4.7
SMC4L1 SMC4 structural maintenance of chromosomes 4-like 1 3.5 8.0
TOPK T-LAK cell-originated protein kinase 3.5 3.4
Cell cycle, meiosis STAG2 Stromal antigen 2 9.2 2.5
DNA replication CDC45L CDC45 cell division cycle 45-like (S. cerevisiae) 0.8 9.0
CDC7 CDC7 cell division cycle 7 (S. cerevisiae) 2.1 5.4
CHAF1A Chromatin ssembly factor 1, subunit A (p150) 1.4 5.9
DNTT Deoxynucleotidyltransferase, terminal 1.2 4.0
DTYMK Deoxythymidylate kinase (thymidylate kinase) 2.1 10.3
MCM3 MCM3 minichromosome maintenance deﬁcient 3 2.8 13.0
MCM7 MCM7 minichromosome maintenance deﬁcient 7 1.9 5.3
MYST2 MYST histone acetyltransferase 2 2.9 14.6
ORC1L Origin recognition complex, subunit 1-like (yeast) 2.0 7.2
ORC3L Origin recognition complex, subunit 3-like (yeast) 1.6 2.1
POLA Polymerase (DNA-directed), alpha 3.0 13.2
POLA2 Polymerase (DNA-directed), alpha (70 kDa) 7.2 21.3
POLD2 Polymerase (DNA-directed), delta 2, 0.6 6.3
POLD3 Polymerase (DNA-directed), delta 3, accessory subunit 2.9 17.0
RPA3 Replication protein A3, 14 kDa 1.9 7.9
Proliferation CCNH Cyclin H 2.4 8.1
EGF Epidermal growth factor 2.0 4.5
MVP Major vault protein 3.5 13.6
PURA Purine-rich element-binding protein A 0.9 5.1
Repair, checkpoint ATR Ataxia telangiectasia-related 1.9 3.9
CCNG2 Cyclin G2 2.9 13.1
CHES1 Checkpoint suppressor 1 2.2 22.4
MTBP Mdm2 binding protein 2.6 3.2
TP53 Tumor protein p53 (Li-Fraumeni syndrome) 1.9 6.0
Repair, homologous RAD51 RAD51 homolog (RecA homolog, E. coli) 2.9 17.0
Repair, mismatch MLH1 MutL homolog 1, colon cancer, nonpolyposis type 2 1.1 5.2
MSH6 MutS homolog 6 (E. coli) 3.5 13.6
PMS1 PMS1 postmeiotic segregation increased 1 2.9 6.3
PMS2L5 Postmeiotic segregation increased 2-like 5 1.2 3.7
The targets are organized in functional classes (column 1). Indicated are the gene symbols (column 2), the enrichment fold in conventional ChIP
assays performed with HeLa cells, either unsynchronized (column 4) or submitted to a thymidine block (column 5). Enrichment of target promoters
was calculated using the G6PDH locus as a reference and is shown relative to the chipped DNA obtained by immunoprecipitation with no antibody.
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within the promoters of target genes (Table 2) (6).
Similarly, other sequences proposed to represent binding
sites for CUX1 were not present more often in the
promoter of target genes (42–44).
p110 CUX1 activates transcription of most cell
cycle-related target genes
To verify the eﬀect of p110 CUX1 on the expression of cell
cycle-related target genes, Hs578T breast tumor cells were
infected with a retrovirus expressing p110 CUX1 or with
an empty retrovirus. This cell line was chosen because in
previous studies using reporter assays it displayed the
greatest fold diﬀerence upon expression of various CUX1
isoforms (12). We postulate, therefore, that the Hs578T
cells express non-limiting amounts of the factors and
co-factors that cooperate with CUX1 in transcriptional
regulation. After 24 h, RNA was puriﬁed from the two
populations of infected cells and the expression of a subset
of genes in each functional class was analyzed by quanti-
tative PCR. In most cases, gene expression was stimulated
in cells that express p110 CUX1, but with some notable
exceptions. Expression of cyclin H and p21WAF1/CKI1 was
reduced, whereas that of MYST2 was not signiﬁcantly
aﬀected (Figure 5 and Table 4). Assuming that changes
in gene expression are a direct consequence of the interac-
tion of p110 CUX1 with the promoter of these genes
(see Discussion section), these results indicate that the
A
B
Western SouthWestern
Probe: ATCGATBlot:1300
Specific Competitor:
Thymidine block:
p200
p110
Non Specific Competitor:
0
0
200
(2N)
400
(4N)
200
400
600
800
1000
0 200
(2N)
400
(4N)
0
200
400
600
800
100063
12
26
57
33
12
Unsynchronized Thymidine Block
1 2 3 4 5 6 7 8
Figure 4. Synchronization of HeLa cells using the thymidine block
procedure. Exponentially growing HeLa cells were submitted to a single
thymidine block. (A) Nuclei were stained with propidium iodide and
DNA content was determined by ﬂuorescence-activated cell sorting
(FACS) analysis. Cell cycle proﬁles were analyzed using the Watson
model and the FlowJoTM software. The numbers above the brackets
indicate the percentage of cells with 2N DNA content (G0/G1 cells),
between 2N and 4N DNA content (S phase cells) and 4N DNA content
(G2/M cells). (B) Nuclear extracts were prepared from synchronized
and unsynchronized cells and were submitted to western and South-
western blot analysis using CUX1 1300 antibodies (Figure 1) and
oligonucleotides containing a consensus-binding site for p110 CUX1:
ATCGAT. Competition experiments were performed in the presence of
an excess amount (1000) of unlabeled speciﬁc or unrelated oligo-
nucleotides (third and fourth panels).
Table 3. ‘ATCRAT’ motif is over-represented in CUX1 cell cycle target genes
Motifs ATCRAT CCAAT CRAT/CRAT CRAT/GYTA
Percentage of promoters with motif(s) Targets 52% 90% 17% 15%
Non-targets 13% 87% 15% 11%
Number of motifs per promoter Targets 0.71 2.40 0.21 0.15
Non-targets 0.15 1.91 0.16 0.11
The promoter regions of target (Table 2) and 50 non-target genes were analyzed for the presence of putative CUX1-binding sites using the
MacVector software. Promoter regions were deﬁned as the sequences that were spotted on the microarray plus 250 bp on each side. R¼A or
G; Y¼T or C. The signiﬁcance of the diﬀerence between Targets and Non-Targets for each motif was determined by Student’s t-test. **P=0.01.
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Figure 5. Expression of most targets is stimulated following transient
expression of p110 CUX1. Hs578T cells were infected with a retrovirus
expressing p110 or with an empty retrovirus. RNA was prepared
24 h post-infection. mRNA expression was measured by quantitative
real-time PCR using primer pairs speciﬁc for CUX1 and for each
target. G6PDH levels were used to normalize the samples. The values
are the mean of three measurements and error bars represent standard
deviation. The fold diﬀerence in expression and P-values are presented
in Table 4.
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regulatory eﬀect of p110 CUX1 is dependent on promoter
context: it functions as a transcriptional activator of most
cell cycle-related target genes, but acts as a repressor of
some speciﬁc targets. These results conﬁrm and extend
previous observations showing that CUX1 represses
the p21WAF1/CKI1 gene but activates the cyclin A2 and
DNA pol alpha genes (1,12,45,46).
The immediate promoter region is sufficient
for the activation by p110 CUX1
To verify whether the 1-Kbp region around the transcrip-
tion start site was suﬃcient to enable regulation by
p110 CUX1, promoter sequences from 15 target genes
were cloned into a luciferase reporter plasmid. Promoter
fragments included the sequences that were spotted on
the microarray plus 250 bp on either side. The two
genes that were repressed in the infection assays, CCNH
and p21WAF1/CKI1, were also repressed in the reporter
assay (Figure 6 and Table 4). Similarly, genes that were
activated in the infection assays were also activated in the
reporter assay, with the exception of HOXA2 (Figure 6
and Table 4). We conclude that the genomic regions
identiﬁed through the ChAP-chip procedure in most
cases contain cis-acting sequences that are suﬃcient for
the regulation by p110 CUX1. The fact that some
promoters were repressed while others were activated
reinforces the notion that the regulatory eﬀect of p110
CUX1 is promoter dependent.
p110 CUX1 stimulates DNA replication
Two classes of genes were clearly dominant among
the validated cell cycle targets of p110 CUX1: genes that
play a role in mitosis and those involved in DNA
replication (Table 2). In previous studies, p110 CUX1
was found to accelerate entry into S phase, however, no
obvious change had been noticed later in the cell cycle
(2,20). We re-investigated this issue, but no change in
the progression through the G2 and M phases were
observed in two cell lines stably expressing p110 CUX1
(Supplementary Figure 10, NIH3T3 and NMuMG).
We then tested whether p110 CUX1 could stimulate
DNA replication. Three approaches were used to test this
hypothesis. First, we measured the expression of DNA
replication gene targets following the inhibition of CUX1
expression by siRNA in NIH3T3 cells. As a control,
cells were treated in a similar manner with a scrambled
RNA sequence. The expression of all 15 DNA replication
targets was reduced, in some cases drastically, concomi-
tantly with the decrease in CUX1 expression (Figure 7).
These results indicate that CUX1 is required for the
maximal expression of DNA replication genes.
Next, we monitored the expression of DNA replication
gene targets following serum starvation/re-stimulation of
NIH3T3 cells stably expressing p110 CUX1 or carrying
the empty vector. Gene expression was measured by
qPCR at 6 (G1), 18 (G1/S) and 24 (S) h after serum
addition as well as in unsynchronized cells. The cell cycle
distribution of cells was determined by FACS analysis
following staining of the DNA with propidium iodide
(Figure 8). The expression of most DNA replication
targets was higher in the p110 CUX1 expressing cells
at the three time points, 6, 18 and 24 h, yet it was still
Table 4. Regulatory interactions between p110 CUX1 and cell cycle
targets
Gene symbol Infection assay Reporter assay
Fold P-value Fold P-value
ANAPC4 2.9 2.0E04
ATR 2.3 1.9E02
CCNA2 9.3 1.5E03 9.0 2.5E03
CCNH 0.34 2.0E02 0.6 1.3E02
CDC25A 4.6 8.0E04 14.1 9.7E03
CDC25B 3.9 5.0E04 8.7 5.7E03
CDC25C 4.7 2.7E03 2.9 1.4E02
CDC45L 2.9 4.8E03
CDC7 5.7 1.4E03
DTYMK 9.7 1.2E02 5.4 9.3E03
EML4 2.1 8.9E03
HOXA2 3.2 1.5E02 1.0 3.9E01
KIF11 10.0 3.8E03
MAD2L1 2.8 1.6E02
MCM3 9.7 1.0E04 5.2 1.0E04
MEIS1 2.2 5.7E03 6.3 1.1E02
MLH1 5.8 2.9E02
MSH6 3.5 1.4E03 8.3 1.8E02
MYST2 1.0 1.6E01 4.3 5.0E04
NUMA1 2.8 5.2E03
ORC1L 1.8 6.1E03 4.4 2.0E03
P21 0.4 3.6E02 0.2 1.0E04
POLD2 2.9 1.1E03
RAD51 4.7 1.8E03 2.9 7.5E03
RPA3 3.2 1.0E03 5.7 1.5E02
The table lists the fold diﬀerence in expression level of endogenous
genes following the infection of Hs578T cells with a p110 CUX1
expression vector (column 2), the P-value of the diﬀerence in expres-
sion (column 3), the fold diﬀerence observed in reporter assays using
plasmids carrying the promoter sequences of various targets
(column 4), and the P-value of the diﬀerence in reporter assays
(column 5). Two rows are highlighted to stress the fact that two targets
were repressed, while most targets were activated.
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regulated in a cell cycle-dependent manner. Thus, the
absolute level of expression for most genes was the highest
at 18 h. The implications of these results in terms of
transcriptional regulation will be discussed below.
Finally, we performed a long-term in vivo DNA replica-
tion assay using a plasmid bearing the oriP replicator of
Epstein Barr virus (EBV). Replication of oriP containing
plasmids depends on cellular factors and occurs no more
than once per cell cycle (47). More eﬃcient replication and
maintenance of the plasmid were observed in Hs578T cells
constitutively expressing p110 CUX1 than in control
cells carrying an empty vector (Figure 9). In contrast,
when a non-replicating plasmid was transfected, no signiﬁ-
cant diﬀerence was observed in the number of resistant
colonies between the two populations (data not shown).
Altogether, the results show that p110 CUX1 is required
for maximal expression of DNA replication genes, and
that constitutive expression of p110 CUX1 not only
can increase the expression of genes involved in DNA
replication but also can stimulate the replication and
maintenance of a plasmid that is controlled by replication
licensing.
DISCUSSION
The goal of this study was to identify the transcrip-
tion targets of p110 CUX1 that are involved in cell
cycle progression. To circumvent the problems due to the
fact that CUX1 antibodies all recognize the full-length
p200 isoform, we expressed a p110-Tag2 recombinant
protein and puriﬁed the chromatin by tandem aﬃnity
chromatography (Figure 1). To validate this approach,
chromatin was puriﬁed in parallel from cells carrying the
empty expression vector and we veriﬁed the enrichment
of two known targets of p110 CUX1 and later, of 36
randomly chosen targets with P-values under 0.005
(Figures 1D and 2). In no case did we observe the enrich-
ment of a known or of a putative target in the chromatin
obtained from cells carrying the vector only. To validate
speciﬁcally the cell cycle targets identiﬁed in location array
analysis, we carried out conventional chromatin immuno-
precipitation with CUX1 antibodies, using a population
of cells enriched in S phase as well as a population of
asynchronously proliferating cells, and we performed
quantitative real-time PCR for each of the 49 cell cycle
targets (Table 2). Overall, the results demonstrated that
the method of ChAP-chip indeed is able to identify
genuine targets with a low rate of false positive. We stress,
however, that this method is valid as long as one is able to
express the recombinant protein at physiological levels.
In our experience, most commonly used expression
vectors are not adequate for this type of procedure.
Only the Rev-TRE retroviral vector, in the absence of a
tetracycline-responsive activator, generated a reasonably
low level of expression that was comparable to that of
endogenous p110 CUX1 (Figure 1B and data not shown).
Our cell synchronization experiment revealed that
CUX1 was recruited to the promoter of cell cycle target
genes more eﬃciently during S phase (Table 2). Interest-
ingly, the proportion of cells in S phase was increased
around 3-fold following the thymidine block. Yet, for
many targets the enrichment was much higher than in
unsynchronized cells, up to 24-fold. The fact that the
enrichment was considerably weaker in asynchronously
proliferating cells helps explain why many targets genes
were originally identiﬁed in only one or two cell lines in
microarray analysis, as opposed to being present in all cell
lines as expected for a cell cycle gene (Table 2). The signal
for any of these genes would be expected to be relatively
weak since most cells in a population of asynchronously
proliferating cells are in G1.
The size and the complexity of CUX1 proteins have
contributed to the diﬃculty in identifying optimal binding
sites for CUX1. One advantage of ChIP and ChAP tech-
nologies is that it enables the unbiased identiﬁcation of
genomic binding sites. The in vivo binding sequences can
then be scanned for the presence of binding motifs that
were established using in vitro binding assays. Among all
putative CUX1-binding sites reported in the literature,
only one, the ATCRAT motif, was found to be over-
represented among targeted sequences as compared to
non-targeted sequences (Table 3). This ﬁnding conﬁrmed
that the ATCRAT motif indeed is a preferred binding
site for p110 CUX1 in vivo. Yet, approximately only one
half of the targeted promoters contained this consensus-
binding site. This proportion is lower than what was
reported for some transcription factors, but this ﬁnding
is not exceptional (32). In a recent study, the E2F1
consensus site was found within 12% of sequences bound
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in vivo (48). We conclude that the recruitment of CUX1
to promoters in vivo can be driven, like E2F1, from its
interaction with low-aﬃnity binding sites and, to a large
extent, from its interaction with other proteins.
A large fraction of genes regulated by p110 CUX1
code for proteins that play a role in mitosis, but we did
not ﬁnd a diﬀerence in the duration of the G2 and
M phases in cells stably expressing this transcription
factor (Supplementary Figure 10). This unexpected result
again is reminiscent of similar ﬁndings obtained with the
E2F transcription factors both in expression proﬁling and
ChIP-chip assays (31,49,50). Yet, to our knowledge,
forced expression of an E2F factor has not been reported
to aﬀect progression through the G2 and M phases. The
failure of these transcription factors to induce a faster
progression at the end of the cell cycle probably reﬂects
the fact that post-transcriptional mechanisms play a
crucial role in the regulation of the G2/M transition and
the progression through M phase. Moreover, the G2-
speciﬁc transcription of some genes was previously shown
to result from the periodic occupation of a repressor
element (51). Nevertheless, it appears that the transcrip-
tional program that leads to the execution of mitosis
begins to be orchestrated during S phase. We can envision
that the start of DNA replication triggers the transcrip-
tional activation of genes whose products will be required
for mitosis and cytokinesis. This does not necessarily
mean that these genes will be turned on immediately, but
that transcriptional complexes must begin to be assembled
on their promoters. Future studies should verify whether
E2F and p110 CUX1 cooperate in the regulation of these
genes.
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Figure 8. Constitutive expression of p110 CUX1 leads to higher expression of DNA replication target genes. RNA was prepared from NIH3T3 cells
stably expressing p110 CUX1 or carrying the empty vector and maintained in various culture conditions. Cells were cultured asynchronously or were
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The eﬀect of p110 CUX1 on the expression of cell cycle-
related targets was investigated using four distinct
approaches: gene expression was measured in cells tran-
siently infected with a retroviral vector expressing p110
CUX1, in cells treated with CUX1 siRNA, in cells stably
expressing p110 CUX1, and in reporter assays. The results
from all these approaches concur to indicate that most cell
cycle targets are activated by p110 CUX1, while a few are
repressed or are unaﬀected. These ﬁndings are in contrast
with the bulk of the literature on CUX1 (1). The reason
for this is that earlier studies focused on the full-length
CUX1 protein which functions exclusively as a repressor.
We previously demonstrated that the removal of the
N-terminal half of the protein, which contains an auto-
inhibitory domain and the Cut repeat 1, has important
consequences on the DNA binding and regulatory proper-
ties of the protein (4,12,13). Yet, despite our progress,
we have yet to uncover the molecular basis for the dual
role of p110 CUX1 as an activator and a repressor. In this
respect, no obvious clue was provided from the analysis
of promoter sequences of two genes that are repressed,
cyclin H and p21WAF1/CKI1, and of genes that are
activated. We surmise that the regulatory eﬀect of p110
CUX1 is determined by the speciﬁc complex it forms with
other partners on distinct promoters.
Our results demonstrated that p110 CUX1 could
stimulate the long-term replication of a plasmid carrying
the oriP replicator from EBV (Figure 9). We believe the
mechanism at play is the early and more pronounced
transcriptional activation of genes that code for products
required for DNA replication. Indeed, expression of many
DNA replication genes was higher in cells expressing
p110 CUX1 than in control cells (Figure 8). Interestingly,
the absolute level of DNA replication gene expression was
highest at 18 h however the fold increase relative to the
vector only cells was already important at 6 h. A number
of observations can be made from the results of this
experiment. First, higher expression of p110 CUX1 is not
suﬃcient to render constitutive the expression of DNA
replication genes. Other regulatory events are required for
their maximal transcription, some that activate the DNA-
binding ability of CUX1 and others that certainly aﬀect
factors that cooperate with CUX1. Second, whether at the
peak of gene expression or earlier in G1, p110 CUX1 is
obviously a limiting factor in the transcriptional activation
of DNA replication genes. Third, it is not clear that the
striking peak in gene expression at 18 h is responsible for
the accelerated S phase entry in cells that constitutively
express p110 CUX1. We think it is likely that the activa-
tion of gene expression earlier in G1 has important conse-
quences. In other words, the quantitative diﬀerence at
18 h may be functionally less relevant than the fact that
the transcriptional program that leads to S phase entry is
initiated earlier in G1. At the molecular level, we envision
that the constitutive expression of p110 CUX1 permits the
precocious assembly of transcriptional complexes on
the promoter of cell cycle genes. Future studies should
attempt to determine whether all or only a small subset of
direct targets contribute to stimulation of DNA replica-
tion and the acceleration of S phase entry.
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Figure 9. Constitutive expression of p110 CUX1 stimulates the long-
term replications and maintenance of an EBV replicon. The pc3oriPE
plasmid that carries oriP, coding sequences for EBNA1 and the
resistance for G418 was transfected into Hs578T/p110 and Hs578T/
vector cells. After transfection, cells were grown under G418 selection
for 10 days and the resistant colonies were visualized by staining with
crystal violet. The images are representative of results obtained in three
separate experiments. Shown in the histogram is the colony density as
measured using the Scion Image 1.63 software.
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